GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (CHIX:SANp) » Definitions » Cash Flow from Others

Sanofi (CHIX:SANP) Cash Flow from Others : €1,865 Mil (TTM As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sanofi Cash Flow from Others?

Sanofi's cash flow from others for the six months ended in Jun. 2024 was €1,153 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Jun. 2024 was €1,865 Mil.


Sanofi Cash Flow from Others Historical Data

The historical data trend for Sanofi's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Cash Flow from Others Chart

Sanofi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only -293.00 -8,001.00 -105.00 20.00 272.00

Sanofi Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 267.00 -247.00 -440.00 712.00 1,153.00

Sanofi Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €1,865 Mil.

Sanofi Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Sanofi's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi Business Description

Address
46, avenue de la Great Army, Paris, FRA, 75017
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.